New National Drug Codes (NDCs) for Etoposide

Original Effective Date: 12/12/2002
Revision Effective Date: 11/01/2013

Suppliers are instructed to bill oral anti-cancer drugs to the DMERCs using the appropriate National Drug Code (NDC) number. Two additional NDC numbers have been added for etoposide products:

  • Etoposide, 50mg, oral NDC #00378-3266-94, (Mylan)
  • Etoposide, 50mg, oral NDC #51079-0965-05, (UDL)

The approval dates of Medicare coverage for the above sources of the drug etoposide are October 29, 2001 for UDL and November 15, 2001 for Mylan.

            Last Updated Tue, 27 Feb 2018 11:42:07 +0000